• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动力肌肉刺激器:对新获得 FDA 510(k)批准的、用于肌肉塑形和美容的设备进行调查。

Powered muscle stimulators: an investigation into newly FDA 510(k) approved devices marketed for muscle toning and esthetic benefit.

机构信息

Northeast Ohio Medical University College of Medicine, Rootstown, OH, USA.

Case Western Reserve University School of Medicine, Cleveland, OH, USA.

出版信息

J Dermatolog Treat. 2020 Mar;31(2):200-203. doi: 10.1080/09546634.2019.1587148. Epub 2019 Mar 19.

DOI:10.1080/09546634.2019.1587148
PMID:30799667
Abstract

Powered muscle stimulators have been popularized in recent years due to their muscle toning effects. This study aims to describe marketing trends and reporting of adverse effects of powered muscle stimulators. We performed a cross-sectional retrospective analysis of records from the United States FDA database for 510(k) premarket approval of powered muscle stimulators between January 1, 2000 and December 31, 2018. The FDA MAUDE database was reviewed for adverse events reported with device usage. One hundred and seventeen devices received 510(k) premarket approval between 2000 and 2018, with the first approval occurring in 2001. Initially, devices were marketed to assist with muscle toning and strengthening, but more recent indications include the treatment of pain, increased local muscle blood circulation, and prevention of post-surgical venous thrombosis. Thirty-six adverse event reports have been submitted and published in the MAUDE database over the past 10 years by 11% of manufacturers. Powered muscle stimulators are growing increasingly popular amongst consumers and healthcare providers due to their ease of use and perceived esthetic, muscle strength, and pain relief benefits. Additional investigation to determine optimal treatment parameters and potential adverse effects is necessary due to the growing popularity of these devices.

摘要

近年来,由于肌肉刺激器具有塑造肌肉的效果,因此受到了广泛的欢迎。本研究旨在描述肌肉刺激器的营销趋势和不良影响报告。我们对美国 FDA 数据库中 2000 年 1 月 1 日至 2018 年 12 月 31 日期间接受 510(k) 上市前批准的动力肌肉刺激器的记录进行了横断面回顾性分析。审查了 FDA MAUDE 数据库中与设备使用相关的不良事件报告。在 2000 年至 2018 年间,有 117 种设备获得了 510(k) 上市前批准,首次批准发生在 2001 年。最初,这些设备被用于辅助肌肉紧致和增强,但最近的适应症包括疼痛治疗、增加局部肌肉血液循环和预防术后静脉血栓形成。在过去的 10 年中,MAUDE 数据库中有 11%的制造商提交并发布了 36 份不良事件报告。由于其易用性以及被认为具有美容、肌肉力量和缓解疼痛的益处,动力肌肉刺激器在消费者和医疗保健提供者中越来越受欢迎。由于这些设备越来越受欢迎,因此有必要进行更多的研究以确定最佳的治疗参数和潜在的不良影响。

相似文献

1
Powered muscle stimulators: an investigation into newly FDA 510(k) approved devices marketed for muscle toning and esthetic benefit.动力肌肉刺激器:对新获得 FDA 510(k)批准的、用于肌肉塑形和美容的设备进行调查。
J Dermatolog Treat. 2020 Mar;31(2):200-203. doi: 10.1080/09546634.2019.1587148. Epub 2019 Mar 19.
2
A review of the FDA's 510(k) approvals process for electromagnetic devices used in body contouring.对 FDA 用于身体塑形的电磁设备 510(k) 审批流程的回顾。
J Dermatolog Treat. 2019 Nov;30(7):727-729. doi: 10.1080/09546634.2019.1566589. Epub 2019 Jun 20.
3
Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports.高风险心血管设备试验中的选择性报告:上市前批准摘要与已发表报告的横断面比较
BMJ. 2015 Jun 10;350:h2613. doi: 10.1136/bmj.h2613.
4
How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?骨科器械在首次获得美国食品药品监督管理局(FDA)上市前批准后会发生怎样的变化?
Clin Orthop Relat Res. 2016 Apr;474(4):1053-68. doi: 10.1007/s11999-015-4634-x. Epub 2015 Nov 19.
5
Shedding light on the FDA's 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia.揭示 FDA 510(k) 审批程序:用于治疗雄激素性脱发的低水平激光治疗设备。
J Dermatolog Treat. 2019 Aug;30(5):489-491. doi: 10.1080/09546634.2018.1528327. Epub 2018 Nov 19.
6
An Analysis of the FDA MAUDE Database and the Search for Cobalt Toxicity in Class 3 Johnson & Johnson/DePuy Metal-on-Metal Hip Implants.对 FDA MAUDE 数据库的分析以及对 3 类强生/DePuy 金属对金属髋关节植入物中钴毒性的研究。
J Patient Saf. 2018 Dec;14(4):e89-e96. doi: 10.1097/PTS.0000000000000534.
7
Orbital Implants Receiving Food and Drug Administration Premarket Notification.接受美国食品和药物管理局上市前通知的眶内植入物。
Ophthalmic Plast Reconstr Surg. 2022;38(5):503-506. doi: 10.1097/IOP.0000000000002228. Epub 2022 Jun 14.
8
United States Food and Drug Administration's 510(k) Pathway: Drawing Implications from the Approvals of Brachytherapy Devices.美国食品药品监督管理局的510(k)路径:从近距离放射治疗设备的批准中得出的启示
Cureus. 2019 Mar 11;11(3):e4230. doi: 10.7759/cureus.4230.
9
Lasers and energy-based devices marketed for vaginal rejuvenation: A cross-sectional analysis of the MAUDE database.用于阴道年轻化的激光和能量型设备:MAUDE数据库的横断面分析
Lasers Surg Med. 2019 Oct;51(8):671-677. doi: 10.1002/lsm.23084. Epub 2019 Mar 29.
10
Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.1979 年至 2015 年初始食品和药物管理局上市前批准后眼科设备寿命期间的增量修订。
Ophthalmology. 2017 Aug;124(8):1237-1246. doi: 10.1016/j.ophtha.2017.03.040. Epub 2017 May 10.

引用本文的文献

1
Radiofrequency and Electrical Muscle Stimulation: A Synergistic Treatment That Achieves Lipolysis and Circumferential Waist Reduction in Noninvasive Body Contouring.射频与电肌肉刺激:一种在非侵入性身体塑形中实现脂肪分解和腰围减小的协同治疗方法。
Aesthet Surg J Open Forum. 2024 May 28;6:ojae042. doi: 10.1093/asjof/ojae042. eCollection 2024.
2
Assessing the Reproducibility of Research Based on the Food and Drug Administration Manufacturer and User Facility Device Experience Data.基于食品和药物管理局制造商和用户设施设备经验数据评估研究的可重复性。
J Patient Saf. 2024 Aug 1;20(5):e45-e58. doi: 10.1097/PTS.0000000000001220. Epub 2024 Mar 12.